Use of acetaminophen during pregnancy and risk of preeclampsia, hypertensive and vascular disorders: A birth cohort study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 5, 2010, Pages 371-378

  Rebordosa, Cristina ^a,b,c   Zelop, Carolyn M ^d   Kogevinas, Manolis ^a,c,e   Sørensen, Henrik T ^f,g   Olsen, Jørn ^h,i  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CRETE   (Greece)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^h AARHUS UNIVERSITY   (Denmark)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular; High risk; Pregnancy; Pregnancy complications; Prostacyclin; Prostaglandin H synthase; Vascular diseases

Indexed keywords

ACETYLSALICYLIC ACID; PARACETAMOL; PROSTACYCLIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE REGISTRY; DRUG USE; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; THIRD TRIMESTER PREGNANCY;

ACETAMINOPHEN; ADULT; ALGORITHMS; ANALGESICS, NON-NARCOTIC; COHORT STUDIES; DENMARK; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; PARTURITION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; RISK; YOUNG ADULT;

EID: 77950838524     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903334877     Document Type: Article

References (30)

1. Noris M, Perico N, Remuzzi G. Mechanisms of disease: preeclampsia. Nat Clin Pract Nephrol 2005;1:98-114.
2. Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152:335-340.
3. Zelop CM. Is it time to re-evaluate our use of acetaminophen in certain sub-gropus of pregnant women? J Matern Fetal Neonat Med 2009;21:761-762.
4. Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006;79: 9-19.
5. Schildknecht S, Daiber A, Ghisla S, Cohen RA, Bachschmid MM. Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite. FASEB J 2008;22:215-224.
6. O'Brien WF, Krammer J, O'Leary TD, Mastrogiannis DS. The effect of acetaminophen on prostacyclin production in pregnant women. Am J Obstet Gynecol 1993;168:1164-1169.
7. Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 1999;282:356-362.
8. Viinikka L, Hartikainen-Sorri AL, Lumme R, Hiilesmaa V, Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclinthromboxane balance in mother and newborn. Br J Obstet Gynaecol 1993;100:809-815.
9. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701-705.
10. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a metanalysis of individual patient data. Lancet 2007;369:1791-1798.
11. Kobayashi T. Antithrombin abnormalities and perinatal management. Curr Drug Targets 2005;6:559-566.
12. Rebordosa C, Kogevinas M, Bech BH, Sorensen HT, Olsen J. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. Int J Epidemiol 2009;38:706-714.
13. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, MacPherson C, Landon M, MiodovnikM, Paul R, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;339:667-671.
14. Ananth CV, Getahun D, Peltier MR, Smulian JC. Placental abruption in term and preterm gestations: evidence for heterogeneity in clinical pathways. Obstet Gynecol 2006; 107:785-792.
15. Lockwood CJ. Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 2006;49:836-843.
16. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, Taxbol D, Hansen KD, Juhl M, Schow TB, et al. The Danish National Birth Cohort - its background, structure and aim. Scand J Public Health 2001;29:300-307.
17. Klemmensen AK, Olsen SF, WengelCM, Tabor A. Diagnostic criteria and reporting procedures for pre-eclampsia: a national survey among obstetrical departments in Denmark. Eur J Obstet Gynecol Reprod Biol 2005;123:41-45.
18. Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 2007; 26:5512-5528.
19. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993;138: 923-936.
20. Oken E, Ning Y, Rifas-Shiman SL, Rich-Edwards JW, Olsen SF, Gillman MW. Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol 2007; 17:663-668.
21. Wilkes JM, Clark LE, Herrera JL. Acetaminophen overdose in pregnancy. South Med J 2005;98:1118-1122.
22. Zusterzeel PL, Peters WH, De Bruyn MA, Knapen MF, Merkus HM, Steegers EA. Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies. Obstet Gynecol 1999;94:1033-1038.
23. Di Ilio C, Tiboni GM, Sacchetta P, Angelucci S, Bucciarelli T, Bellati U, Aceto A. Time-dependent and tissue-specific variations of glutathione transferase activity during gestation in the mouse. Mech Ageing Dev 1995;78:47-62.
24. Nohr EA, Frydenberg M, Henriksen TB, Olsen J. Does low participation in cohort studies induce bias? Epidemiology 2006;17:413-418.
25. Allais G, Castagnoli GI, Airola G, Schiapparelli P, Terzi MG, Mana O, Benedetto C. Is migraine a risk factor in pregnancy? Neurol Sci 2007;28:S184-S187.
26. Larsen TB, Johnsen SP, Moller CI, Larsen H, Sorensen HT. A review of medical records and discharge summary data found moderate to high predictive values of discharge diagnoses of venous thromboembolism during pregnancy and postpartum. J Clin Epidemiol 2005;58:316-319.
27. Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol 2007;166:117-124.
28. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353:1258-1265.
29. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention [CPEP] Study Group. Am J Obstet Gynecol 1997;177:1003-1010.
30. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-241